首页> 美国卫生研究院文献>Heliyon >Quantification of cobalt and nickel in urine using inductively coupled plasma atomic emission spectroscopy
【2h】

Quantification of cobalt and nickel in urine using inductively coupled plasma atomic emission spectroscopy

机译:电感耦合等离子体原子发射光谱法定量尿液中钴和镍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cobalt and nickel are micronutrients indispensable for the body, therefore, their use with food or as part of vitamin complexes is necessary to maintain health. As a result, trace cobalt and nickel contents are present in human biological fluids – blood and urine. According to the World Anti-Doping Agency prohibited list, they belong to the group of blood doping preparations – erythropoiesis stimulants. Nowadays, methods for their control in biological fluids are being actively developed to establish reasonable allowable contents of these trace elements in human biological fluids. However, in addition to developing highly sensitive methods for the determination of the total content of cobalt and nickel using ICP-MS and ETAAS, the development and comparison of various sample preparation methods that can provide the greatest accuracy, reproducibility and express analysis are also relevant. In the present paper, a comparison of different sample preparation methods – direct analysis, dilution and microwave mineralization of urine samples was shown, the detection and quantification limits were compared, some metrological characteristics that can be achieved using these sample preparation methods were evaluated. The procedure was tested on artificial and real urine samples. Taking the course of vitamin complexes in therapeutic concentrations was shown not to lead to a significant increase in the concentrations of analytes in urine, while taking elevated concentrations (for example, 2-fold) makes it possible to determine them even using ICP-AES. However, even in this case, cobalt and nickel concentrations remain at a relatively low level, not able to lead to a significant increase in erythropoiesis.
机译:钴和镍是对身体不可或缺的微量营养素,因此,它们与食物的用途或作为维生素复合物的一部分来保持健康。结果,人体生物流体 - 血液和尿液中存在痕量钴和镍含量。根据世界反兴奋剂机构禁止清单,它们属于血液掺杂制剂组 - 促红细胞兴奋剂兴奋剂。如今,正在积极开发用于它们在生物流体中的控制方法,以建立这些微量元素在人的生物流体中的合理允许含量。然而,除了使用ICP-MS和ETAAS测定钴和镍的总含量的高敏感方法外,各种样品制备方法的开发和比较也可以提供最大的准确性,再现性和表达分析也是相关的。在本文中,示出了不同样品制备方法的比较 - 示出了尿液样品的直接分析,稀释和微波矿化,比较了检测和定量限制,评价了可以使用这些样品制备方法实现的一些计量特性。该程序在人工和真正的尿液样本上进行了测试。在治疗浓度下采取维生素复合物的过程不导致尿液中分析物浓度的显着增加,同时采取升高的浓度(例如,2倍),使得即使使用ICP-AES也可以确定它们。然而,即使在这种情况下,钴和镍浓度也仍处于相对较低的水平,不能导致促红细胞的显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号